Liquid injection aims to last longer for prostate relief
NCT ID NCT07255508
Summary
This study is testing a liquid embolic agent called SQUIDPERI for treating bothersome urinary symptoms caused by an enlarged prostate (BPH). The procedure, called Prostatic Artery Embolization (PAE), blocks blood flow to shrink the prostate. Researchers want to see if using this liquid agent is effective and provides longer-lasting symptom relief compared to other methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Arnaud de Villeneuve (Service Imagerie diagnostique et interventionnelle)
Montpellier, 34295, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Européen Georges Pompidou - AP-HP (Radiologie Interventionnelle vasculaire et oncologique)
Paris, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Timone (Radiologie adultes et neuroradiologie)
Marseille, 13385, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Cardiovasculaire de Strasbourg (ICS) - Clinique Rhena (Radiologie interventionnelle vasculaire et oncologique)
Strasbourg, 67000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.